No ovarian cancer was reported, which may not be surprising given the fact that ovarian cancer penetrance is significantly lower in BRCA2 mutation carriers compared to BRCA1. Although prostate cancer is part of the BRCA2 cancer susceptibility spectrum, no prostate cancer was reported as well. This evidence concerns the gene BRCA2 and cancer.